Search clinical trials for: doxylamine succinate

Total 458 results

NYU Langone Health

Terminated

Feasibility of "At-home" Titration of Solifenacin

Overactive Bladder
Luye Pharma Group Ltd.

Completed

Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005

Major Depressive Disorder, Recurrent, Unspecified

United States
Fundació Sant Joan de Déu

Completed

Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis

Bronchiolitis, Viral
University of Michigan
Forest Laboratories

Completed

Nebivolol Versus Sustained Release Metoprolol Succinate in Patients With Chronic Kidney Disease

Chronic Kidney Disease

United States
National Taiwan University Hospital

Unknown

Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients

Overactive Bladder Syndrome

Taiwan
Guang'anmen Hospital of China Academy of Chinese...
Beijing Hospital; Capital Medical University

Unknown

Treatment, Parallel Assignment, Double Blind (Subject, Outcomes Assessor), Efficacy Study

Overactive Bladder

China
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive Patients (CREATIVE)

Hypertension

China
GlaxoSmithKline

Completed

Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks

Migraine | Migraine Disorders

United States
University of British Columbia
Pfizer

Completed

Neurocognition and Work Productivity in Major Depressive Disorder (MDD)

Major Depressive Disorder

Canada
Klinikum der Universität Köln

Unknown

Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women (URGE-I)

Urge Urinary Incontinence

Germany
Klinikum der Universität Köln

Unknown

Treatment of Urge Urinary Incontinence in Women After Failure of Cesa or Vasa (URGE-II)

Surgical Treatment of Urge Incontinence

Germany
Hotel-Dieu Grace Healthcare

Unknown

Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular Depression

Vascular Depression

Canada
BC Women's Hospital & Health Centre

Completed

Functional Outcome in Postpartum Depression in Women Treated With Desvenlafaxine

Depression

Canada
Soonchunhyang University Hospital

Completed

The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)

Overactive Bladder

Korea, Republic of
Advanced Research Network
Astellas Pharma US, Inc.

Terminated

VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate

Over-Active Bladder

United States
University of Calgary
University of Alberta

Unknown

Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis

Major Depressive Disorder

Canada
Emory University
Forest Laboratories

Completed

Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells

Hypertension

United States
Thomas Jefferson University
Forest Laboratories

Completed

Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood Pressure (ENCOMPASS)

Hypertension | Peripheral Artery Disease

United States
Pfizer

Completed

Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder

Major Depressive Disorder

Canada, United States, Colombia, Croatia, Estonia, Finland, Poland, France, Slovakia, Chile, Latvia, Lithuania, Romania, South Africa
Luye Pharma Group Ltd.

Completed

Safety, Tolerability and Pharmacokinetics Study of LY03005 (LY03005SAD)

Major Depressive Disorder

United States
Centre for Addiction and Mental Health

Completed

Desvenlafaxine Monotherapy in Dysthymia

Dysthymic Disorder

Canada
Boehringer Ingelheim

Completed

Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, Compared to Metoprolol Succinate and Placebo in Healthy Volunteers

Healthy
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

Childhood Diffuse Large Cell Lymphoma | Childhood Immunoblastic Large Cell Lymphoma | Childhood Burkitt Lymphoma | Untreated Childhood Acute Lymphoblastic Leukemia | Stage I Childhood Large Cell Lymphoma | Stage I Childhood Small Noncleaved Cell Lymphoma | Stage II Childhood Large Cell Lymphoma | Stage II Childhood Small Noncleaved Cell Lymphoma and other conditions

United States
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) (SOLAR)

Overactive Bladder | Urinary Incontinence | Urge Incontinence

France, Belgium, Spain, Turkey, Australia, Russian Federation, Hungary, Italy, Netherlands, Poland, Czech Republic
Astellas Pharma Inc

Completed

Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder (VERSUS)

Urinary Bladder, Overactive

United States
Astellas Pharma Inc

Completed

A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men. (VICTOR)

Urinary Incontinence

United States
Astellas Pharma Inc

Completed

Solifenacin Succinate Versus Tolterodine 4mg Once Daily (STAR)

Urinary Bladder, Overactive

France, United Kingdom, Spain, Belarus, Belgium, Ukraine, Denmark, Greece, Russian Federation, Czech Republic, Netherlands, Germany, Hungary, Italy, Slovakia, Sweden, Norway
Astellas Pharma Inc

Completed

A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB) (VENUS)

Urinary Bladder, Overactive

United States
Astellas Pharma Inc

Completed

Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms (SUNRISE)

Urinary Bladder, Overactive

France, United Kingdom, Belgium, Germany, Spain, Portugal, Greece, Russian Federation, Czech Republic, Poland, Hungary, Italy, Slovakia, Egypt
Astellas Pharma Inc

Completed

Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms (VOLT)

Urinary Bladder, Overactive

United States
Boehringer Ingelheim

Terminated

Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension

Hypertension
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis (CARE Cirrhosis)

Cirrhosis | Cardiac Remodeling | Cirrhotic Cardiomyopathy

Brazil
Astellas Pharma Inc

Completed

Post Marketing Survey of Vesicare in Japan (SET-Q)

Overactive Bladder

Japan
AstraZeneca

Completed

Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients

Angina Pectoris

China
Astellas Pharma Europe B.V.

Completed

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects

Healthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)

Germany
Astellas Pharma Inc

Completed

A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH (SATURN)

Lower Urinary Tract Symptoms | Prostatic Hyperplasia

France, Poland, Germany, Spain, Finland, Netherlands, Russian Federation, Czech Republic, Hungary, Norway, Denmark, Slovakia, Sweden, Austria, Portugal, United Kingdom
NeurAxon Inc.

Completed

Study of NXN 188 for the Treatment of Migraine With Aura

Migraine With Aura

United States
Astellas Pharma Inc

Completed

Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction

Lower Urinary Tract Symptoms | Bladder Outlet Obstruction

United States, Czech Republic, Poland, Hungary, Belgium, Germany
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Leukemia

United States, Australia, Canada
Children's Oncology Group
National Cancer Institute (NCI); Children's Cancer and Leukaemia Group; Societe...

Completed

TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

France, United Kingdom
Astellas Pharma Europe B.V.

Completed

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects

Healthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)

Germany
Astellas Pharma Inc
Astellas Pharma Korea, Inc.

Completed

A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment (RESORT-2)

Over Active Bladder

Korea, Republic of
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosin When Administered in a Combination Tablet

Healthy Subjects | Drug-Drug Interaction (DDI)

France
Asan Medical Center
Samsung Medical Center; Seoul National University Hospital; Cheil General Hospital... and other collaborators

Completed

Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin (OAB)

Overactive Bladder

Korea, Republic of
Astellas Pharma Europe B.V.

Completed

A Study to Compare the Amount of Drug in the Blood After a Single Tablet EC905 Containing Solifenacin and Tamsulosin is Taken by Healthy Males Compared to Separate Tablets of Solifenacin and Tamsulosin

Healthy Subjects | Pharmacokinetics | EC905

United Kingdom
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate How Tamsulosin (at 1 Dose) and Solifenacin (at 2 Different Doses) Are Taken up From the Intestine, Distributed Through the Body and Eliminated From the Body When Administered in Combination as a Single Tablet (Called EC905)

Healthy Subjects | Pharmacokinetics | EC905 | Multiple Dose

United Kingdom
Bay State Clinical Trials, Inc.

Terminated

Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder

Overactive Bladder

United States
Mayo Clinic
Forest Laboratories

Terminated

Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients? (Inapprop)

Hypertension

United States
Dr Cipto Mangunkusumo General Hospital
Astellas Pharma Indonesia Inc.; Pharos Life Corporation

Unknown

The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females

Urinary Tract Infection

Indonesia
Peking Union Medical College Hospital
Astellas Pharma China, Inc.; Beijing CAT Science Co., Ltd.

Completed

Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women (OAB)

Overactive Bladder | Urination Disorders | Postmenopausal Disorder

China

Search clinical trials for: doxylamine succinate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations